NEW YORK (GenomeWeb News) – More than half of the companies operating in the omics tools and molecular diagnostics space saw their stock prices drop in April, resulting in a sluggish GenomeWeb Daily News Index for the month.

Of the 29 firms in the GWDN Index, 16 declined during the past month, and overall the index inched up less than 1 percent. It trailed the Dow Jones Industrial Average and the Nasdaq, which grew a little less than 2 percent each, as well as the Nasdaq Biotech Index, which gained almost 8 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.